tiprankstipranks
Fennec Pharmaceuticals (TSE:FRX)
TSX:FRX
Holding TSE:FRX?
Track your performance easily

Fennec Pharmaceuticals (FRX) Financial Statements

13 Followers

Fennec Pharmaceuticals Financial Overview

Fennec Pharmaceuticals's market cap is currently ―. The company's EPS TTM is C$-0.143; its P/E ratio is -45.92; Fennec Pharmaceuticals is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is C$-0.15. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 7.26M$ 27.51M$ 9.73M$ 6.51M$ 3.33M
Gross Profit$ 6.65M$ 24.83M$ 9.05M$ 6.18M$ 3.18M
EBIT$ -4.51M$ 13.87M$ -1.77M$ -1.01M$ -4.63M
EBITDA$ -4.49M$ 13.89M$ -1.70M$ -939.00K$ -4.56M
Net Income Common Stockholders$ -5.55M$ 12.84M$ -2.68M$ -1.87M$ -5.45M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 43.05M$ 51.18M$ 13.27M$ 12.40M$ 14.96M
Total Assets$ 63.16M$ 69.19M$ 26.86M$ 19.03M$ 19.44M
Total Debt$ 29.77M$ 29.75M$ 29.73M$ 24.72M$ 24.68M
Net Debt$ -13.29M$ -21.43M$ 16.46M$ 12.32M$ 9.72M
Total Liabilities$ 64.52M$ 66.18M$ 38.49M$ 29.56M$ 29.16M
Stockholders Equity$ -1.36M$ 3.01M$ -11.62M$ -10.53M$ -9.73M
Cash Flow-
Free Cash Flow$ -8.39M$ 39.05M$ -4.86M$ -2.76M$ -3.95M
Operating Cash Flow$ -8.39M$ 39.05M$ -4.86M$ -2.76M$ -3.95M
Investing Cash Flow-----
Financing Cash Flow$ 257.00K$ -1.13M$ 5.73M$ 201.00K$ 514.00K
Currency in USD

Fennec Pharmaceuticals Earnings and Revenue History

Fennec Pharmaceuticals Debt to Assets

Fennec Pharmaceuticals Cash Flow

Fennec Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis